A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet's Syndrome
| Autor: | E. Khan, N. L. Ambrose, J. Ahnström, A. P. Kiprianos, M. R. Stanford, D. Eleftheriou, P.A. Brogan, J. C. Mason, M. Johns, M. A. Laffan, D. O. Haskard |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: | |
| Zdroj: | Khan, E, Ambrose, N L, Ahnström, J, Kiprianos, A P, Stanford, M R, Eleftheriou, D, Brogan, P A, Mason, J C, Johns, M, Laffan, M A & Haskard, D O 2016, ' A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet's Syndrome ', Scientific Reports, vol. 6, 38104 . https://doi.org/10.1038/srep38104 |
| DOI: | 10.1038/srep38104 |
| Popis: | Thrombosis is common in Behçet's Syndrome (BS), and there is a need for better biomarkers for risk assessment. As microparticles expressing Tissue Factor (TF) can contribute to thrombosis in preclinical models, we investigated whether plasma microparticles expressing Tissue Factor (TF) are increased in BS. We compared blood plasma from 72 healthy controls with that from 88 BS patients (21 with a history of thrombosis (Th+) and 67 without (Thâ '). Using flow cytometry, we found that the total plasma MP numbers were increased in BS compared to HC, as were MPs expressing TF and Tissue Factor Pathway Inhibitor (TFPI) (all p 0.7 had a history of clinical thrombosis. We conclude that TF-expressing MP are increased in BS and that an imbalance between microparticulate TF and TFPI may predispose to thrombosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|